The role of telomere trimming in normal telomere length dynamics

Cell Cycle

Volumn 11, Issue 7, 2012, Pages 1309-1315

  Pickett, Hilda A ^a   Reddel, Roger R ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Alternative lengthening of telomeres; Homologous recombination; Telomerase; Telomere length; Telomere rapid deletion; Telomere trimming

Indexed keywords

DNA;

CELL CYCLE; CELL PROLIFERATION; DNA DAMAGE; DNA STRUCTURE; DNA SYNTHESIS; HUMAN; NONHUMAN; REVIEW; TELOMERE;

EID: 84860324635     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.19632     Document Type: Review

References (78)

1. de Lange T. Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev 2005; 19:2100-10; PMID:16166375; http://dx.doi.org/ 10.1101/gad.1346005.
2. d'Adda di Fagagna F, Reaper PM, Clay-Farrace L, Fiegler H, Carr P, Von Zglinicki T, et al. A DNA damage checkpoint response in telomere-initiated senescence. Nature 2003; 426:194-8; PMID:14608368; http://dx.doi.org/10.1038/ nature02118.
3. Kaul Z, Cesare AJ, Huschtscha LI, Neumann AA, Reddel RR. Five dysfunctional telomeres predict onset of senescence in human cells. EMBO Rep 2011; 13:52-9; PMID:22157895; http://dx.doi.org/10.1038/embor.2011.227.
4. McClintock B. The stability of broken ends of chromosomes in Zea mays. Genetics 1941; 26:234-82; PMID:17247004.
5. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100:57-70; PMID:10647931; http://dx.doi.org/10.1016/S0092-8674(00)81683-9.
6. Tsakiri KD, Cronkhite JT, Kuan PJ, Xing C, Raghu G, Weissler JC, et al. Adult-onset pulmonary fibrosis caused by mutations in telomerase. Proc Natl Acad Sci USA 2007; 104:7552-7; PMID:17460043; http://dx.doi.org/10.1073/pnas. 0701009104.
7. Armanios MY, Chen JJ, Cogan JD, Alder JK, Ingersoll RG, Markin C, et al. Telomerase mutations in families with idiopathic pulmonary fibrosis. N Engl J Med 2007; 356:1317-26; PMID:17392301; http://dx.doi.org/10.1056/NEJMoa066157.
8. Alder JK, Guo N, Kembou F, Parry EM, Anderson CJ, Gorgy AI, et al. Telomere length is a determinant of emphysema susceptibility. Am J Respir Crit Care Med 2011; 184:904-12; PMID:21757622; http://dx.doi.org/10.1164/rccm.201103- 0520OC.
9. Lou Z, Wei J, Riethman H, Baur JA, Voglauer R, Shay JW, et al. Telomere length regulates ISG15 expression in human cells. Aging (Albany NY) 2009; 1:608-21; PMID:20157543.
10. Cohen SB, Graham ME, Lovrecz GO, Bache N, Robinson PJ, Reddel RR. Protein composition of catalytically active human telomerase from immortal cells. Science 2007; 315:1850-3; PMID:17395830; http://dx.doi.org/10.1126/science. 1138596.
11. Savage SA, Bertuch AA. The genetics and clinical manifestations of telomere biology disorders. Genet Med 2010; 12:753-64; PMID:21189492; http://dx.doi.org/10.1097/GIM.0b013e3181f415b5.
12. Zhong F, Savage SA, Shkreli M, Giri N, Jessop L, Myers T, et al. Disruption of telomerase trafficking by TCAB1 mutation causes dyskeratosis congenita. Genes Dev 2011; 25:11-6; PMID:21205863; http://dx.doi.org/10.1101/ gad.2006411.
13. Shay JW, Bacchetti S. A survey of telomerase activity in human cancer. Eur J Cancer 1997; 33:787-91; PMID:9282118; http://dx.doi.org/10.1016/S0959- 8049(97)00062-2.
14. Heaphy CM, Subhawong AP, Hong SM, Goggins MG, Montgomery EA, Gabrielson E, et al. Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes. Am J Pathol 2011; 179:1608-15; PMID:21888887; http://dx.doi.org/10.1016/j.ajpath.2011.06.018.
15. Bryan TM, Englezou A, Gupta J, Bacchetti S, Reddel RR. Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J 1995; 14:4240-8; PMID:7556065.
16. Counter CM, Avilion AA, LeFeuvre CE, Stewart NG, Greider CW, Harley CB, et al. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 1992; 11:1921-9; PMID:1582420.
17. Counter CM, Botelho FM, Wang P, Harley CB, Bacchetti S. Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes. J Virol 1994; 68:3410-4; PMID:8151802.
18. Baird DM. Variation at the TERT locus and predisposition for cancer. Expert Rev Mol Med 2010; 12:16; PMID:20478107; http://dx.doi.org/10.1017/ S146239941000147X.
19. Hills M, Lansdorp PM. Short telomeres resulting from heritable mutations in the telomerase reverse transcriptase gene predispose for a variety of malignancies. Ann NY Acad Sci 2009; 1176:178-90; PMID:19796246; http://dx.doi.org/10.1111/j.1749-6632.2009.04565.x.
20. Gilson E, Londoño-Vallejo A. Telomere length profiles in humans: all ends are not equal. Cell Cycle 2007; 6:2486-94; PMID:17726375; http://dx.doi.org/10.4161/cc.6.20.4798.
21. Olovnikov AM. A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. J Theor Biol 1973; 41:181-90; PMID:4754905; http://dx.doi.org/ 10.1016/0022-5193(73)90198-7.
22. Watson JD. Origin of concatemeric T7 DNA. Nat New Biol 1972; 239:197-201; PMID:4507727.
23. Levy MZ, Allsopp RC, Futcher AB, Greider CW, Harley CB. Telomere end-replication problem and cell aging. J Mol Biol 1992; 225:951-60; PMID:1613801; http://dx.doi.org/10.1016/0022-2836(92)90096-3.
24. Wellinger RJ, Ethier K, Labrecque P, Zakian VA. Evidence for a new step in telomere maintenance. Cell 1996; 85:423-33; PMID:8616897; http://dx.doi.org/10.1016/S0092-8674(00)81120-4.
25. Makarov VL, Hirose Y, Langmore JP. Long G tails at both ends of human chromosomes suggest a C strand degradation mechanism for telomere shortening. Cell 1997; 88:657-66; PMID:9054505; http://dx.doi.org/10.1016/S0092-8674(00) 81908-X.
26. Reddel RR. Senescence: an antiviral defense that is tumor suppressive? Carcinogenesis 2010; 31:19-26; PMID:19887513; http://dx.doi.org/10.1093/carcin/ bgp274.
27. Pickett HA, Cesare AJ, Johnston RL, Neumann AA, Reddel RR. Control of telomere length by a trimming mechanism that involves generation of t-circles. EMBO J 2009; 28:799-809; PMID:19214183; http://dx.doi.org/10.1038/emboj.2009.42.
28. Moyzis RK, Buckingham JM, Cram LS, Dani M, Deaven LL, Jones MD, et al. A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc Natl Acad Sci USA 1988; 85:6622-6; PMID:3413114; http://dx.doi.org/10.1073/pnas.85.18.6622.
29. de Lange T, Shiue L, Myers RM, Cox DR, Naylor SL, Killery AM, et al. Structure and variability of human chromosome ends. Mol Cell Biol 1990; 10:518-27; PMID:2300052.
30. Wright WE, Tesmer VM, Huffman KE, Levene SD, Shay JW. Normal human chromosomes have long G-rich telomeric overhangs at one end. Genes Dev 1997; 11:2801-9; PMID:9353250; http://dx.doi.org/10.1101/gad.11.21.2801.
31. Griffith JD, Comeau L, Rosenfield S, Stansel RM, Bianchi A, Moss H, et al. Mammalian telomeres end in a large duplex loop. Cell 1999; 97:503-14; PMID:10338214; http://dx.doi.org/10.1016/S0092-8674(00)80760-6.
32. Pickett HA, Henson JD, Au AY, Neumann AA, Reddel RR. Normal mammalian cells negatively regulate telomere length by telomere trimming. Hum Mol Genet 2011; 20:4684-92; PMID:21903669; http://dx.doi.org/10.1093/hmg/ddr402.
33. Roth M, Prescott DM. DNA intermediates and telomere addition during genome reorganization in Euplotes crassus. Cell 1985; 41:411-7; PMID:2985276; http://dx.doi.org/10.1016/S0092-8674(85)80014-3.
34. Larson DD, Spangler EA, Blackburn EH. Dynamics of telomere length variation in Tetrahymena thermophila. Cell 1987; 50:477-83; PMID:3607876; http://dx.doi.org/10.1016/0092-8674(87)90501-0.
35. Kyrion G, Boakye KA, Lustig AJ. C-terminal truncation of RAP1 results in the deregulation of telomere size, stability and function in Saccharomyces cerevisiae. Mol Cell Biol 1992; 12:5159-73; PMID:1406688.
36. Li B, Lustig AJ. A novel mechanism for telomere size control in Saccharomyces cerevisiae. Genes Dev 1996; 10:1310-26; PMID:8647430; http://dx.doi.org/10.1101/gad.10.11.1310.
37. Bucholc M, Park Y, Lustig AJ. Intrachromatid excision of telomeric DNA as a mechanism for telomere size control in Saccharomyces cerevisiae. Mol Cell Biol 2001; 21:6559-73; PMID:11533244; http://dx.doi.org/10.1128/MCB.21.19.6559- 73.2001.
38. Polotnianka RM, Li J, Lustig AJ. The yeast Ku heterodimer is essential for protection of the telomere against nucleolytic and recombinational activities. Curr Biol 1998; 8:831-4; PMID:9663392; http://dx.doi.org/10.1016/ S0960-9822(98)70325-2.
39. Lustig AJ. Clues to catastrophic telomere loss in mammals from yeast telomere rapid deletion. Nat Rev Genet 2003; 4:916-23; PMID:14634639; http://dx.doi.org/10.1038/nrg1207.
40. Joseph I, Jia D, Lustig AJ. Ndj1p-dependent epigenetic resetting of telomere size in yeast meiosis. Curr Biol 2005; 15:231-7; PMID:15694306; http://dx.doi.org/10.1016/j.cub.2005.01.039.
41. Trelles-Sticken E, Dresser ME, Scherthan H. Meiotic telomere protein Ndj1p is required for meiosis-specific telomere distribution, bouquet formation and efficient homologue pairing. J Cell Biol 2000; 151:95-106; PMID:11018056; http://dx.doi.org/10.1083/jcb.151.1.95.
42. Watson JM, Shippen DE. Telomere rapid deletion regulates telomere length in Arabidopsis thaliana. Mol Cell Biol 2007; 27:1706-15; PMID:17189431; http://dx.doi.org/10.1128/MCB.02059-06.
43. Wang RC, Smogorzewska A, de Lange T. Homologous recombination generates T-loop-sized deletions at human telomeres. Cell 2004; 119:355-68; PMID:15507207; http://dx.doi.org/10.1016/j.cell.2004.10.011.
44. Cesare AJ, Griffith JD. Telomeric DNA in ALT cells is characterized by free telomeric circles and heterogeneous t-loops. Mol Cell Biol 2004; 24:9948-57; PMID:15509797; http://dx.doi.org/10.1128/MCB.24.22.9948-57.2004.
45. Fouché N, Cesare AJ, Willcox S, Ozgür S, Compton SA, Griffith JD. The basic domain of TRF2 directs binding to DNA junctions irrespective of the presence of TTA GGG repeats. J Biol Chem 2006; 281:37486-95; PMID:17052985; http://dx.doi.org/10.1074/jbc.M608778200.
46. Deng Z, Dheekollu J, Broccoli D, Dutta A, Lieberman PM. The origin recognition complex localizes to telomere repeats and prevents telomere-circle formation. Curr Biol 2007; 17:1989-95; PMID:18006317; http://dx.doi.org/10.1016/ j.cub.2007.10.054.
47. Machwe A, Xiao L, Orren DK. TRF2 recruits the Werner syndrome (WRN) exonuclease for processing of telomeric DNA. Oncogene 2004; 23:149-56; PMID:14712220; http://dx.doi.org/10.1038/sj.onc.1206906.
48. Opresko PL, von Kobbe C, Laine JP, Harrigan J, Hickson ID, Bohr VA. Telomere-binding protein TRF2 binds to and stimulates the Werner and Bloom syndrome helicases. J Biol Chem 2002; 277:41110-9; PMID:12181313; http://dx.doi.org/10.1074/jbc.M205396200.
49. Li B, Jog SP, Reddy S, Comai L. WRN controls formation of extrachromosomal telomeric circles and is required for TRF2DeltaB-mediated telomere shortening. Mol Cell Biol 2008; 28:1892-904; PMID:18212065; http://dx.doi.org/10.1128/MCB.01364-07.
50. Wang Y, Ghosh G, Hendrickson EA. Ku86 represses lethal telomere deletion events in human somatic cells. Proc Natl Acad Sci USA 2009; 106:12430-5; PMID:19581589; http://dx.doi.org/10.1073/pnas.0903362106.
51. Fink LS, Lerner CA, Torres PF, Sell C. Ku80 facilitates chromatin binding of the telomere binding protein, TRF2. Cell Cycle 2010; 9:3798-806; PMID:20890109; http://dx.doi.org/10.4161/cc.9.18.13129.
52. Zellinger B, Akimcheva S, Puizina J, Schirato M, Riha K. Ku suppresses formation of telomeric circles and alternative telomere lengthening in Arabidopsis. Mol Cell 2007; 27:163-9; PMID:17612498; http://dx.doi.org/10.1016/ j.molcel.2007.05.025.
53. Hande MP, Balajee AS, Tchirkov A, Wynshaw-Boris A, Lansdorp PM. Extra-chromosomal telomeric DNA in cells from Atm(-/-) mice and patients with ataxia-telangiectasia. Hum Mol Genet 2001; 10:519-28; PMID:11181576; http://dx.doi.org/10.1093/hmg/10.5.519.
54. Vidacek NS, Cukusi A, Ivankovi M, Fulgosi H, Huzak M, Smith JR, et al. Abrupt telomere shortening in normal human fibroblasts. Exp Gerontol 2010; 45:235-42; PMID:20080170; http://dx.doi.org/10.1016/j.exger.2010.01.009.
55. Henson JD, Reddel RR. Assaying and investigating Alternative Lengthening of Telomeres activity in human cells and cancers. FEBS Lett 2010; 584:3800-11; PMID:20542034; http://dx.doi.org/10.1016/j.febslet.2010.06.009.
56. Henson JD, Neumann AA, Yeager TR, Reddel RR. Alternative lengthening of telomeres in mammalian cells. Oncogene 2002; 21:598-610; PMID:11850785; http://dx.doi.org/10.1038/sj.onc.1205058.
57. Dlaska M, Anderl C, Eisterer W, Bechter OE. Detection of circular telomeric DNA without 2D gel electrophoresis. DNA Cell Biol 2008; 27:489-96; PMID:18694327; http://dx.doi.org/10.1089/dna.2008.0741.
58. Britt-Compton B, Rowson J, Locke M, Mackenzie I, Kipling D, Baird DM. Structural stability and chromosome-specific telomere length is governed by cis-acting determinants in humans. Hum Mol Genet 2006; 15:725-33; PMID:16421168; http://dx.doi.org/10.1093/hmg/ddi486.
59. Baird DM, Britt-Compton B, Rowson J, Amso NN, Gregory L, Kipling D. Telomere instability in the male germline. Hum Mol Genet 2006; 15:45-51; PMID:16311252; http://dx.doi.org/10.1093/hmg/ddi424.
60. Allen ND, Baird DM. Telomere length maintenance in stem cell populations. Biochim Biophys Acta 2009; 1792:324-8; PMID:19419691.
61. Henson JD, Cao Y, Huschtscha LI, Chang AC, Au AY, Pickett HA, et al. DNA C-circles are specific and quantifiable markers of alternative-lengthening-of- telomeres activity. Nat Biotechnol 2009; 27:1181-5; PMID:19935656; http://dx.doi.org/10.1038/nbt.1587.
62. Ancelin K, Brunori M, Bauwens S, Koering CE, Brun C, Ricoul M, et al. Targeting assay to study the cis functions of human telomeric proteins: evidence for inhibition of telomerase by TRF1 and for activation of telomere degradation by TRF2. Mol Cell Biol 2002; 22:3474-87; PMID:11971978; http://dx.doi.org/10. 1128/MCB.22.10.3474-87.2002.
63. Smogorzewska A, van Steensel B, Bianchi A, Oelmann S, Schaefer MR, Schnapp G, et al. Control of human telomere length by TRF1 and TRF2. Mol Cell Biol 2000; 20:1659-68; PMID:10669743; http://dx.doi.org/10.1128/MCB.20.5.1659- 68.2000.
64. Smogorzewska A, de Lange T. Regulation of telomerase by telomeric proteins. Annu Rev Biochem 2004; 73:177-208; PMID:15189140; http://dx.doi.org/ 10.1146/annurev.biochem.73.071403.160049.
65. Bianchi A, Shore D. How telomerase reaches its end: mechanism of telomerase regulation by the telomeric complex. Mol Cell 2008; 31:153-65; PMID:18657499; http://dx.doi.org/10.1016/j.molcel.2008.06.013.
66. Cristofari G, Lingner J. Telomere length homeostasis requires that telomerase levels are limiting. EMBO J 2006; 25:565-74; PMID:16424902; http://dx.doi.org/10.1038/sj.emboj.7600952.
67. Amiard S, Doudeau M, Pinte S, Poulet A, Lenain C, Faivre-Moskalenko C, et al. A topological mechanism for TRF2-enhanced strand invasion. Nat Struct Mol Biol 2007; 14:147-54; PMID:17220898; http://dx.doi.org/10.1038/nsmb1192.
68. Poulet A, Buisson R, Faivre-Moskalenko C, Koelblen M, Amiard S, Montel F, et al. TRF2 promotes, remodels and protects telomeric Holliday junctions. EMBO J 2009; 28:641-51; PMID:19197240; http://dx.doi.org/10.1038/emboj.2009.11.
69. Compton SA, Choi JH, Cesare AJ, Ozgür S, Griffith JD. Xrcc3 and Nbs1 are required for the production of extrachromosomal telomeric circles in human alternative lengthening of telomere cells. Cancer Res 2007; 67:1513-9; PMID:17308089; http://dx.doi.org/10.1158/0008-5472.CAN-06-3672.
70. Gire V, Roux P, Wynford-Thomas D, Brondello JM, Dulic V. DNA damage checkpoint kinase Chk2 triggers replicative senescence. EMBO J 2004; 23:2554-63; PMID:15192702; http://dx.doi.org/10.1038/sj.emboj.7600259.
71. Buscemi G, Zannini L, Fontanella E, Lecis D, Lisanti S, Delia D. The shelterin protein TRF2 inhibits Chk2 activity at telomeres in the absence of DNA damage. Curr Biol 2009; 19:874-9; PMID:19375317; http://dx.doi.org/10.1016/j. cub.2009.03.064.
72. Raices M, Verdun RE, Compton SA, Haggblom CI, Griffith JD, Dillin A, et al. C. elegans telomeres contain G-strand and C-strand overhangs that are bound by distinct proteins. Cell 2008; 132:745-57; PMID:18329362; http://dx.doi.org/ 10.1016/j.cell.2007.12.039.
73. Oganesian L, Karlseder J. Mammalian 5′ C-rich telomeric overhangs are a mark of recombination-dependent telomere maintenance. Mol Cell 2011; 42:224-36; PMID:21504833; http://dx.doi.org/10.1016/j.molcel.2011.03.015.
74. Herbig U, Jobling WA, Chen BP, Chen DJ, Sedivy JM. Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53 and p21(CIP1), but not p16(INK4a). Mol Cell 2004; 14:501-13; PMID:15149599; http://dx.doi.org/10.1016/S1097-2765(04)00256-4.
75. Hemann MT, Strong MA, Hao LY, Greider CW. The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell 2001; 107:67-77; PMID:11595186; http://dx.doi.org/10.1016/S0092- 8674(01)00504-9.
76. Rubelj I, Vondracek Z. Stochastic mechanism of cellular aging - abrupt telomere shortening as a model for stochastic nature of cellular aging. J Theor Biol 1999; 197:425-38; PMID:10196087; http://dx.doi.org/10.1006/jtbi.1998.0886.
77. Baird DM, Rowson J, Wynford-Thomas D, Kipling D. Extensive allelic variation and ultrashort telomeres in senescent human cells. Nat Genet 2003; 33:203-7; PMID:12539050; http://dx.doi.org/10.1038/ng1084.
78. Britt-Compton B, Baird DM. Intra-allelic mutation at human telomeres. Biochem Soc Trans 2006; 34:581-2; PMID:16856866; http://dx.doi.org/10.1042/ BST0340581.